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A B S T R A C T   
Sorbitol dehydrogenase (SDH) activity is one of the most sensitive and specific markers for hepatocellular injury 
in horses, but its reported lability makes it impractical for use in many clinical settings. To date, stability of SDH 
in equine samples has only been evaluated in a limited number of studies in serum samples of horses with ac-
tivities within reference intervals. The objective of the study was to determine pre-analytical stability of equine 
SDH activity in heparinized plasma stored at different temperatures for up to 72 h. Twenty client-owned horses 
admitted to a veterinary teaching hospital for any reason were included in the study. Blood samples collected in 
lithium-heparin tubes were immediately centrifuged and SDH activity was analyzed within 1 h of collection (T0). 
Aliquots of plasma were stored at room temperature, 4 ◦C and − 20 ◦C and SDH activity was re-analyzed after 4 h 
(T4), 24 h (T24) and 72 h (T72). 
A significant difference from values measured at T0 was found for samples stored at room temperature (P =
0.022) and − 20 ◦C (P < 0.001), but not at 4 ◦C. The activity of SDH was within ±20% of that measured at T0 for 
all samples under all temperature conditions stored for 4 h, and for all samples stored at 4 ◦C for 24 h. 
Bland–Altman plots revealed narrow limits of agreement at T4 for all storage temperatures and at T24 for 
samples stored at 4 ◦C. The mean absolute percentage error and 95th percentile of the absolute percentage error 
were lower for samples stored at 4 ◦C than those stored at room temperature or − 20 ◦C. The activity of SDH has 
adequate stability for 4 h regardless of storage temperature and 24 h if stored at 4 ◦C across a wide range of 
values. Knowledge of the pre-analytical stability of SDH may permit its broader use in assessing hepatic disorders 
in horses.   
Introduction 
Hepatic disorders are common in horses (DeNotta and Divers, 2020); 
diagnosis generally relies on a combination of clinical signs, clinico-
pathologic findings, ultrasound imaging and liver biopsy (Durham et al., 
2003a,b,c). Detection of increased hepatic enzyme activities in serum or 
plasma is important when establishing a diagnosis of equine hepatop-
athy and, when evaluated over time, may help predict prognosis 
(Durham et al., 2003a; DeNotta and Divers, 2020). While elevations in 
some enzyme activities (alkaline phosphatase, aspartate aminotrans-
ferase, lactate dehydrogenase) may indicate hepatobiliary disorders, 
only γ-glutamyl transferase (gGT), glutamate dehydrogenase (GLDH) 
and sorbitol dehydrogenase (SDH) are considered liver specific in 
horses. Both SDH and GLDH are considered specific for hepatocellular 
damage, and gGT is primarily associated with biliary disease, but may 
also increase with hepatocellular injury (DeNotta and Divers, 2020). 
Sorbitol dehydrogenase (also known as iditol dehydrogenase) is a 
cytosolic enzyme, found in the highest concentrations in the liver and is 
a very sensitive and specific marker of liver disease (Bernard and Divers, 
1989; El-Kabbani et al., 2004). The half-life of equine SDH is very short 
and has been reported to be in the range of 12− 24 h (Engelking and 
Paradis, 1987). Given this short half-life, SDH is of potential benefit for 
monitoring horses with acute hepatic injury (Divers, 2015). Indeed, SDH 
activity has been shown to increase above baseline as early as 4 h after 
oral administration of carbon tetrachloride, peak after two days, and 
decrease to baseline within 5 days (Bernard and Divers, 1989). 
Despite these potential advantages, SDH is not offered by many 
veterinary laboratories because it is known to be very labile. In one 
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study, serum SDH activity in 9 horses was stable for only 5 h at room 
temperature (21 ◦C), 24 h refrigerated (0–5 ◦C) and 48 h in frozen 
samples (− 30 ◦C) (Horney et al., 1993). The same study measured SDH 
in equine heparinized plasma and found increased activity in samples 
refrigerated for 5 h, but did not evaluate stability in frozen samples 
(Horney et al., 1993). Comparable stability of SDH was found in serum 
from cows and llamas (Horney et al., 1993; Tornquist et al., 2000). 
However, these studies only included samples with SDH activities within 
reference intervals, and no study has evaluated the stability of equine 
SDH in heparinized plasma samples from animals with both normal and 
increased activities. 
The objective of this study was therefore to evaluate the effect of 
storage time and temperature on SDH activity in equine plasma samples 
with normal and increased activities stored for up to 72 h at room 
temperature, refrigerated, and frozen. 
Materials and methods 
Animals 
The study population consisted of horses referred to an equine hos-
pital for any reason, including suspicion of liver disease, to cover a broad 
range of SDH activities. Horses were enrolled if a biochemistry profile 
that included SDH activity was requested by the attending clinician for 
diagnostic work-up and owner consent was obtained to use the 
remaining portion of samples for research purposes. Ethical approval 
was waived by the institutional ethics committee as all samples were 
taken for diagnostic purposes and only leftover material was used in this 
study. Consent was obtained from the owners for all diagnostic pro-
cedures and for the use of leftover biological material for research 
purposes. 
Specimen collection and analysis 
Blood (9 mL) was collected into lithium-heparinized blood tubes (S- 
Monovette Sarstedt) and samples were centrifuged immediately at 1400 
× g for 10 min at room temperature. Plasma was removed directly after 
centrifugation and aliquoted. Baseline plasma SDH activity was 
measured within one hour of sample collection (T0). The remaining 
aliquots were immediately stored for 4 h (T4), 24 h (T24) and 72 h (T72) 
at room temperature, 4 ◦C and − 20 ◦C prior to analysis. Samples were 
allowed to come to room temperature (30 min) and vortexed for 5 s prior 
to analysis. Storage duration times were chosen to reflect the three most 
common scenarios of sample submission by private practitioners to the 
veterinary laboratory, namely same-day delivery, next-day delivery, or 
Monday morning delivery of samples taken on Fridays. Temperatures 
were monitored every 20 min using electronic temperature recorders 
(TRID30-7, LogTag Recorders Ltd, Spaelti-TS AG) and storage was 
considered acceptable if temperatures remained within 18–25 ◦C (room 
temperature), 2–6 ◦C (refrigerated at 4 ◦C) and − 18 to − 22 ◦C (frozen at 
− 20 ◦C). Plasma SDH activity was measured with a commercial 
biochemical analyzer (Cobas c501, Roche Diagnostics) using a com-
mercial SDH reagent (VetSpec, C432-0B, Catachem), and two levels of 
controls (VetSpec, C434-41; C434-42, lot DL281801 and lot DA292003, 
Catachem), following manufacturer’s guidelines. Analyzer observed 
total error (TEobs) was calculated as follows -  
TEobs = 2CV + bias% (Harr et al., 2013).                                                
All measurements performed for the same animal at the same time- 
point were measured in a single run. 
Statistical analysis 
Data were analyzed using statistical software (Medcalc Statistical 
Software version 19.6, Medcalc Software). As data was not normally 
distributed (Shapiro–Wilk), a Friedman test was used to evaluate mea-
surements at different time points for each of the three different storage 
temperatures. Where significant differences were found, post-hoc anal-
ysis was performed using pairwise Wilcoxon signed-rank tests with 
Bonferroni correction to assess differences between each time point and 
T0. Bland-Altman plots were created using values at T0 as the reference 
method and plotting the percentage differences between values at a 
given time point and the value at T0 against the value at T0. The median 
absolute percentage error and 95th percentile of the median absolute 
percentage error were also calculated, whereby the absolute percentage 
error was calculated as -  
100 × (absolute value [y-x]/x)                                                                 
where y is SDH activity at a given time point and x is SDH activity at T0. 
The 95th percentile is interpreted as the percentage difference between 
the activity at a given time point and that at T0 that is not expected, with 
95% certainty, to be exceeded. A P-value <0.05 was considered signif-
icant. Independent of statistical significance, we considered values 
within ±25% of that measured at T0 to be a “clinically acceptable” total 
allowable error (Harr et al., 2013). 
Results 
The study included 20 horses between 1 and 30 years of age (mean ±
standard deviation [SD]; 14 ± 8.3 years). There were 8 mares and 12 
geldings and the following breeds were represented: Warmblood (n = 5), 
Irish Cob (n = 3), Freiberger (n = 2), Welsh pony (n = 2), Friesian (n =
2), Crossbred pony (n = 2), Arabian (n = 1), German riding pony (n = 1), 
Paint horse (n = 1), Shetland pony (n = 1). 
Baseline SDH activity measured at T0 ranged between 6 and 98 U/L 
(Table 1). Based on a reference interval of 3–16 U/L, 4 horses had SDH 
activity within reference limits (range, 6–15 U/L), 9 had values between 
the upper reference limit (URL) and 2× the URL (range, 18–29 U/L), 3 
had values between 2× and 3× the URL (range, 34–44 U/L) and 4 horses 
had activities over 3× the URL (range, 58–98 U/L). 
Controls were within limits published by the manufacturer, and 
analyzer TEobs was within (20.0%; high level) or very close to (25.3%; 
low level) the total allowable error of 25%, recommended for SDH (Harr 
et al., 2013). 
The activity of SDH was within ±20% of that measured at T0 for all 
samples under all temperature conditions stored for 4 h, and for all 
samples stored at 4 ◦C for 24 h. No significant difference (P = 0.060) was 
found between values at T0 and values measured after storage at 4 ◦C 
(Fig. 1). However, significant differences were found between values at 
T0 and values measured after storage at room temperature (P = 0.022) 
and − 20◦C (P < 0.001). Post hoc analyses revealed significant differ-
ences at T24 and T72 for samples stored at room temperature, and T4 
Table 1 
Comparison of SDH activities in equine plasma after 0 h (T0), 4 h (T4), 24 h 
(T24), and 72 h (T72) of storage at different temperatures.  
Temperature Time 
point 







T0 20 27.5 18.5–42.5 6–98  
T4 20 26.5 18.0–42.5 6–97 0.252 
T24 20 24.0 17.5–45.0 6–85 0.039 
T72 20 24.5 14.0–44.5 6–84 0.010 
4 ◦C 
T0 20 27.5 18.5–42.5 6–98  
T4 20 26.5 18.5–42.5 6–100 n/a 
T24 20 26.0 18.5–43.0 6–91 n/a 
T72 20 25.0 18.0–42.5 6–119 n/a 
− 20 ◦C 
T0 20 27.5 18.5–42.5 6–98  
T4 20 26.0 17.5–39.0 7–100 0.031 
T24 20 25.0 18.5–39.0 6–94 0.010 
T72 20 24.5 17.0–38.5 5–126 0.429 
Min, Minimum; Max, Maximum; n/a, not applicable. 
a Difference compared to T0, Wilcoxon signed-rank (Bonferroni corrected). 
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and T24 for samples stored at − 20 ◦C (Table 1). Bland-Altman plots 
revealed narrow limits of agreement at T4 for all storage temperatures, 
and at T24 for samples stored at 4 ◦C (Fig. 2). A negative proportional 
bias was present with increasing SDH activity after storage at room 
temperature for 24 and 72 h, and a positive proportional bias was 
evident after storage at − 20 ◦C for 72 h. The mean absolute percentage 
error and 95th percentile of the absolute percentage error were lower for 
samples stored at 4 ◦C than those stored at room temperature or − 20 ◦C 
(Table 2). Changes in SDH activity under all investigated storage con-
ditions did not affect the clinical classification regarding presence or 
absence of hepatocellular disease in any of our studied horses. 
Data from the temperature monitoring devices revealed that storage 
temperatures were within the acceptable range at all time points except 
for minor fluctuations for refrigerated samples (minimum recorded 
temperature, 1.8 ◦C; maximum recorded temperature 7.5 ◦C). 
Discussion 
Biochemical markers that clearly differentiate between horses with 
and without liver disease are currently lacking (Durham et al., 2003b), 
and a combination of diagnostic tests is needed to identify affected an-
imals. Measurement of SDH activity is generally underused due to 
concerns regarding its stability, but a greater understanding of SDH 
stability could allow for wider use of this enzyme in the evaluation of 
suspected hepatopathies in horses (Pieralisi and Comazzi, 2006). 
The results of this study indicate that SDH activity in heparinized 
plasma may be more stable at 4 ◦C than at either room temperature or 
− 20 ◦C if samples are centrifuged, and plasma separated and refriger-
ated immediately after collection. Analysis after 4 and 24 h storage at 4 
◦C yielded limits of agreement within ±20% of activity at T0 and may 
thus be acceptable when used to screen for evidence of equine liver 
disease. However, the limits of agreement and 95th percentile absolute 
percentage error were relatively high and increased over time regardless 
of storage temperature, limiting the use of SDH activity for serial mea-
surements in horses if timely analysis is not possible. Nonetheless, a 
change in enzyme activity beyond the 95th percentile absolute per-
centage error found in this study is less likely to be attributable to 
storage alone, and may therefore still be interpreted as clinically rele-
vant, particularly if changes also exceeded the TEobs of 25%. Further-
more, it is noteworthy that storage conditions investigated herein would 
not have led to a clinical misclassification of presence or absence of 
hepatic disease in any of our studied horses. 
These findings suggest a higher stability of SDH in equine plasma 
than previously reported for equine serum samples (Horney et al., 
1993). Higher stability of SDH in plasma than in serum after 24 h storage 
at room temperature was also reported in llamas, although this finding 
was not confirmed in refrigerated or frozen samples (Tornquist et al., 
2000). 
Some samples showed higher activity after storage, especially for 
samples stored at − 20 ◦C. This has previously been reported for SDH 
(Tornquist et al., 2000) and other biochemical analytes (Ada et al., 
2017). It has been hypothesized, that the enzyme became more 
concentrated or that its activity increased at lower temperatures 
(Tornquist et al., 2000). Some of the results might also be explained by 
intra-sample variance as previously described especially when analyzing 
small data sets (Rendle et al., 2009). Analytical variation, such as re-
action temperature, reagent degradation, differences in calibration, in-
strument imprecision or drift, as well as operator imprecision, may also 
contribute to the measured differences in SDH activities, but are unlikely 
to account solely for the large changes observed with prolonged storage 
at room temperature and − 20 ◦C. Nevertheless, all samples stored for 4 h 
at all temperatures and all stored for 24 h at 4 ◦C were both within the 
25% total allowable error recommended for SDH (Harr et al., 2013) and 
our TEobs. 
The effect of delayed centrifugation on SDH activity was not inves-
tigated in this study, but it has previously been shown to have a sig-
nificant effect on the activity of enzymes in horses including aspartate 
dehydrogenase, creatine kinase and lactate dehydrogenase (Rendle 
et al., 2009). Whether and to what extent delayed centrifugation and 
plasma separation may affect plasma SDH activity in equine samples 
Fig. 1. Dot-and-line diagrams showing sorbitol dehydrogenase (SDH) activities in plasma in 20 horses after 0 h (T0), 4 h (T4), 24 h (T24), and 72 h (T72) of storage 
at room temperature (1a), 4 ◦C (1b) and at − 20 ◦C (1c). Reference intervals: 3–16 U/L. 
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Fig. 2. Bland–Altman plots after storage of equine plasma for 4 h (T4), 24 h (T24) and 72 h (T72) showing sorbitol dehydrogenase (SDH) activities as the percentage 
difference between values after storage and values prior to storage (T0) plotted against values at T0 at room temperature (2a), 4 ◦C (2b) and − 20 ◦C (2c). Dotted 
black line, zero line; solid blue line, average difference; black bar, 95% CI for the average difference; dashed blue lines, limits of agreement; blue bars, 95% con-
fidence intervals (CI) for the limits of agreement; dash/dotted black line, regression line; solid black lines, 95% CI for the regression. 
Table 2 
Mean percentage difference, limits of agreement, and absolute percentage error of sorbitol dehydrogenase (SDH) activities in equine plasma after storage at room 








Lower limit of 
agreement 
(95% CI) 











− 2.42 (− 4.94 to 0.12) 
− 13.00 (− 17.39 to 
− 8.61) 8.16 (3.77 to 12.55) 0.57 (0.00 to 3.57) 16.61 
T24 − 6.83 (− 12.66 to 
− 0.99) 
− 31.27 (− 41.41 to 
− 21.12) 
17.60 (7.46 to 27.75) 8.83 (4.65 to 17.33) 25.99 
T72 − 12.54 (− 20.17 to 
− 4.91) 
− 44.50 (− 57.77 to 
− 31.23) 
19.42 (6.15 to 32.69) 13.56 (6.94 to 24.33) 37.53 
T4 
4 ◦C 
− 1.57 (− 4.48 to 1.34) 
− 13.76 (− 18.82 to 
− 8.70) 10.62 (5.56 to 15.68) 0.00 (0.00 to 3.80) 15.14 
T24 − 1.00 (− 5.25 to 3.25) 
− 18.79 (− 23.17 to 
− 11.40) 16.79 (9.40 to 24.17) 3.71 (2.57 to 7.10) 20.37 
T72 − 2.35 (− 9.04 to 4.34) − 30.35 (− 41.98 to 
− 18.73) 
25.66 (14.03 to 
37.28) 
7.69 (3.93 to 11.11) 32.13 
T4 
− 20 ◦C 
− 5.25 (− 9.35 to 
− 1.16) 
− 22.42 (− 29.54 to 
− 15.29) 
11.91 (4.78 to 19.03) 6.98 (2.27 to 11.01) 20.47 
T24 
− 5.89 (− 10.75 to 
− 1.03) 
− 26.23 (− 34.68 to 
− 17.79) 14.45 (6.01 to 22.90) 4.67 (3.42 to 10.55) 25.82 
T72 − 6.35 (− 13.95 to 1.25) 
− 38.17 (− 51.38 to 
− 24.97) 
25.47 (12.26 to 
38.68) 14.23 (8.15 to 17.48) 29.80 
CI, confidence intervals. 
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therefore warrants further investigation. 
As only SDH and GLDH are considered specific for hepatocellular 
injury in horses, many veterinary diagnostic laboratories offer mea-
surement of GLDH only, due to concerns regarding the stability of SDH. 
Rare studies have investigated the relative sensitivities and specificities 
of these two enzymes or their comparative usefulness as prognostic 
markers. In one study, both enzymes were found to have comparable 
sensitivity and specificity, but the assay used for SDH activity differed 
from that used in the present study (West, 1989). Further investigation 
and comparison of both enzyme activities in the diagnostic workup of 
equine hepatopathies are necessary to assess the potential use of 
measuring SDH or both enzymes compared to GLDH alone. 
Limitations of this study include a small sample set with a majority of 
increased SDH concentrations. A priori estimates for ANOVA repeated 
measures were not performed to determine the optimal number of study 
subjects due to the lack of reliable estimates for effect size. In addition, 
duplicate measurements of each sample may also have given insight into 
the coefficient of variation due to the method alone. Although there 
were some fluctuations in refrigeration temperatures, these were very 
minor and unlikely to have had any marked influence on results. 
Nevertheless, the study results suggest that SDH can be used in clinical 
practice if blood samples are centrifuged and plasma separated imme-
diately after venipuncture, and if samples can be analyzed within 4 h or 
refrigerated and analyzed within 24 h. The results further indicate that 
results of frozen plasma samples should be interpreted with caution 
despite previous studies suggesting adequate stability in frozen serum 
samples. 
Conclusions 
Equine SDH activity was stable in heparinized plasma stored under 
all temperature conditions for 4 h and at 4 ◦C for 24 h, but changes in 
enzyme activity may only be considered clinically relevant if they 
exceed 25% of previously measured activity. Results of this study may 
permit wider use of SDH activity in assessing hepatic disorders in horses. 
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